CF
38
-3
GIS
54
2
VZ
25
-2
UNP
50
4
ECL
84
14
FE
41
2
VFC
45
3
AVGO
57
-14
ALL
45
-3
DNB
36
2
EW
40
2
MCD
46
4
KMI
55
-4
IPG
42
-2
AVY
74
2
DE
29
-3
FLR
36
-3
URBN
70
4
HRL
29
2
HAL
41
11
CF
38
-3
GIS
54
2
VZ
25
-2
UNP
50
4
ECL
84
14
FE
41
2
VFC
45
3
AVGO
57
-14
ALL
45
-3
DNB
36
2
EW
40
2
MCD
46
4
KMI
55
-4
IPG
42
-2
AVY
74
2
DE
29
-3
FLR
36
-3
URBN
70
4
HRL
29
2
HAL
41
11
Financhill
Back

Nasdaq Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
48

NDAQ
Nasdaq

Last Price:
60.26
Seasonality Move:
6.29%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
48
Nasdaq (NDAQ) is a Sell

Is Nasdaq a Buy, Sell or Hold?

  • The current Nasdaq [NDAQ] share price is $60.26. The Score for NDAQ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • NDAQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NDAQ Stock Price Chart

What is Nasdaq's stock price today?

  • The Nasdaq share price today is $60.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NDAQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NDAQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 53.7 Buy
Chaikin Money Flow: 1844154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.69 - 61.55) Buy
Bollinger Bands (100): (57.45 - 61.75) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

NDAQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.18 Buy
20-day SMA: 59.53 Buy
50-day SMA: 60.37 Sell
200-day SMA: 56.35 Buy
8-day EMA: 59.35 Buy
20-day EMA: 59.62 Buy
50-day EMA: 59.97 Buy
200-day EMA: 57.76 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Nasdaq Earnings Growth & NDAQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.13 per share, and an increase next year of $0.34 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Nasdaq Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):